Abstract
RNASEH2A was demonstrated to be highly upregulated in aggressive prostate cancer to degrade R-loop accumulation and preserve genomic stability for tumor growth, suggesting that RNase H2 activity could be a promising therapeutic target.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have